Symbol: |
ETHE1
|
Description: |
ethylmalonic encephalopathy 1 [Source:HGNC Symbol;Acc:23287]
|
Location: |
Chr19:44010872-44031396[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:176
Gene |
Compound |
Gen_sig |
Exp_pattern |
ETHE1 |
NSC 678154 |
0.002 |
Up |
ETHE1 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- |
0.021 |
Up |
ETHE1 |
Adenine, 9-[1,2-bis(ethoxycarbonyl)ethenyl]-, trans- |
0.008 |
Up |
ETHE1 |
2-[(4-Methylphenyl)sulfinyl]-3-furancarboxaldehyde |
0.012 |
Up |
ETHE1 |
NSC 680338 |
0.022 |
Up |
ETHE1 |
NSC 680417 |
0.004 |
Up |
ETHE1 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,leucine deriv. |
0.005 |
Up |
ETHE1 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,methionine deriv. |
0.001 |
Up |
ETHE1 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline,isoleucine deriv. |
0.005 |
Up |
ETHE1 |
Propanimidoyl chloride, 2-methyl-N-[[[[4-(methoxy- carbonyl)phenyl]amino]carbonyl]oxy]- |
0.043 |
Up |
ETHE1 |
Propanimidoyl chloride, N-[[[(4-methoxyphenyl)amino] carbonyl]oxy]- |
0.028 |
Up |
ETHE1 |
Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- |
0.003 |
Up |
ETHE1 |
NSC 683555 |
0.001 |
Up |
ETHE1 |
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4-ethyl- 11-[[[4-[[5,5a,6,8,8a,9-hexahydro-5-(4-hydroxy- 3,5-dimethoxyphenyl)-6-oxofuro[3',4':6,7]naphtho[2,3-d]- 1,3-dioxol-9-yl]amino]phenyl]imino]methyl]-4-hydroxy-, hydrochloride, ste |
0.005 |
Up |
ETHE1 |
NSC 685283 |
0.021 |
Up |
Expression pattern: Sensitivity / Resistance
Total:12 Current:7
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:1
SNP |
Gene |
SNP_location |
SNP_allele |
rs201842186 |
ETHE1 |
Chr19:44010947 |
C/A |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:15
Total:1 Current:1
[First] [Prev] [Next] [Last]
|